SageView Advisory Group’s Mesoblast MESO Stock Holding History

SageView Advisory Group’s Portfolio MESO Stock Details MESO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$199	Buy	+11	New	+$189	﹤0.01%	2512

Other funds holding MESO

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

AAP

Arax Advisory Partners Denver, Colorado $3.54B AUM 19.14% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Penbrook Management New York $132M AUM 29.91% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SageView Advisory Group's MESO Position: Q4 2025 in Review

SageView Advisory Group opened a new position in Mesoblast (MESO) in Q4 2025: 11 shares worth $199. The stake represents ﹤0.01% of the portfolio and ranks #2512 among its holdings.

74 funds tracked by Wall St. Rank hold MESO as of Q4 2025.

SageView Advisory Group held 11 shares of Mesoblast worth $199 as of Q4 2025.
Mesoblast was a new SageView Advisory Group position in Q4 2025.
Mesoblast made up ﹤0.01% of SageView Advisory Group's portfolio in Q4 2025, its #2512 holding.
74 funds tracked by Wall St. Rank held Mesoblast as of Q4 2025.

Based on SageView Advisory Group's 13F filing for Q4 2025, filed 17 Feb 2026.